FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.
Blood Adv
; 5(15): 3021-3031, 2021 08 10.
Article
in En
| MEDLINE
| ID: mdl-34357379
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Multiple Myeloma
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2021
Document type:
Article
Country of publication:
United States